Selling capacity and capability, not a branded product.
Contract development and manufacturing organisations sell manufacturing capability, capacity and regulatory track record to pharmaceutical companies, which means the site has to answer a technical buyer’s specific evaluation questions quickly.
A pharmaceutical company evaluating a CDMO is checking capacity, capability by dosage form or modality, regulatory track record and facility credentials, usually against several competing CDMOs at once. Vague capability statements lose to specific, checkable ones.
Content structured around capability by dosage form, modality and scale, facility and regulatory credential information presented clearly, and a site built for a technical buyer comparing several providers.
Everything we present about your credentials comes verified from your quality and regulatory function, structured so a buyer evaluating a CDMO partner can check it quickly rather than dig for it.
The scope our work with CDMO companies has operated within.
The build priorities for a technical B2B evaluation differ from a consumer-facing business. Here is what CDMO companies most often need.
How this work is approached specifically for CDMO.
What comes up when building for a manufacturing and development organisation.
We structure that evidence for you rather than verifying it ourselves — facility certifications, audit outcomes, and available capacity by dosage form come from your quality and operations team, and we present it in the format a pharmaceutical buyer’s supplier qualification process expects. That usually means clear documentation links and current capacity status rather than a general capabilities statement.
It can show current availability if your operations team maintains that data in a system we can connect to, though few CDMOs update it frequently enough for true real time. More commonly we show capacity by dosage form and modality at a coarser, regularly refreshed level of detail, which is specific enough for a buyer’s shortlist decision without needing minute-by-minute accuracy.
Indirectly — making your capability easy to find and evaluate quickly affects whether you make the shortlist in the first place, which happens before any RFP is issued. The RFP response itself remains your team’s work and expertise; our role is ensuring the buyer already understands your dosage form range, modality, and scale before that document lands on their desk.
Yes — see technical SEO audit for how we make sure capability content is findable by the specific technical terms a buyer searches, such as dosage form, modality, or batch scale, rather than only the generic company name searches most CDMO sites already rank for. That distinction matters because technical searchers rarely start with your brand name.
Related sectors worth reviewing alongside CDMO.
Capability that is not reaching the buyers evaluating providers. Tell us your specialisation and we will tell you how we would approach it for a CDMO.